Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: Tempus ai - What They Never Told You

ARPA-H Funds AI Agents Designed to Adjust Heart Failure Medications, Testing How Much Autonomy Patients Can Trust

ARPA-H picked teams to build AI agents that could adjust heart failure care, aiming for FDA authorization. Safety questions patients should ask.

Medical Daily

Dear Tempus AI Stock Fans, Mark Your Calendars for July 30

Tempus AI is set to report its Q2 results today. Investors will be watching.

Barchart

Nancy Pelosi, Donald Trump Bet On The Same 10 Stocks – Some Might Surprise You (CORRECTED)

Editor’s Note: This story has been updated to correct details related to Intel (INTC).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Tempus AI Stock Faces a Make-or-Break Moment After Its Recent Pullback

Tempus AI's stock has hit a rough patch, but fundamentals remain solid. What does it mean for investors?

Barchart

How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here

While investors are scaling back the AI-at-any-cost narrative, TEM stock brings to the table a highly speculative but enticing bullish trade.

Barchart

Why Ark Invest's Cathie Wood Keeps Selling AMD — And Which AI Stocks She's Buying Instead

Cathie Wood's ARK Invest continues to sell AMD shares while ramping its stake in Tempus AI, reflecting strategic shifts amid rising memory costs and supply constraints.

International Business Times UK

After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound

Revisit Tempus AI after its post-earnings drop: Q4 growth vs. acquisition lift, 2026 EBITDA inflection guidance, dataset scale, and analyst targets.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building

Tempus AI posted an 83% revenue jump and raised guidance, yet shares fell. See analyst targets, institutional buying, margin trends, and key risks.

MarketBeat

Cathie Wood Adds 210K Shares to a Rising AI Bet With Upside of 102%

Wall Street believes this Cathie Wood-approved stock has more room to run.

Barchart

Pelosi’s Bullish 2026 Buy List: AI, Power & Dividends

The famous congressional portfolio is rotating capital into dividend-paying financial stocks while doubling down on artificial intelligence and energy.

MarketBeat

Cathie Wood Invests Millions in Tempus AI and George Soros-Backed Autonomous Firm After Major Announcement

Cathie Wood's Ark Invest has increased its holdings in Tempus AI and Kodiak AI in recent trades, as these firms accelerate their AI development and collaboration efforts for rapid growth.

International Business Times UK

5 Tech Stocks Insiders Are Selling (But Smart Investors Are Loading Up)

Insiders are selling tech stocks after the massive rally in 2025. Some are up by 300% or more, providing attractive exits for execs. Investors shouldn't follow.

MarketBeat

Tempus AI: Volatility Equates to Opportunity in AI Leader

Tempus AI is well-positioned to accelerate growth as its investments in healthcare-focused AI pay off. Analysts are raising their targets.

MarketBeat

Tempus AI Q3 Highlights: Cathie Wood-, Nancy Pelosi-Owned AI Stock Raises Guidance

AI company Tempus AI (NASDAQ:TEM) reported third-quarter financial results Tuesday after market close.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Ark Invest Dumps AMD Stock, Doubles Down On Chinese Tech Giants Alibaba And Baidu

On Thursday, Cathie Wood‘s Ark Invest made significant trades involving Alibaba Group Holding Ltd (NYSE:BABA), Baidu Inc (NASDAQ:BIDU), Advanced Micro Devices Inc (NASDAQ:AMD), and Tempus AI Inc (NASDAQ:TEM). These trades reflect Ark’s strategic positioning in the tech sector, with purchases and sales across multiple funds.

Benzinga

Tempus AI Shares Are Trading Higher Monday: What's Going On?

Tempus AI (NASDAQ:TEM) shares are trading higher Monday after the company announced its subsidiary, Ambry Genetics, published a peer reviewed study in Genetics in Medicine.

Benzinga

IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

Benzinga

Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership

Whitehawk Therapeutics Inc. (NASDAQ:WHWK) dropped 8.81% in after-hours trading Thursday, closing at $2.38, after announcing a multi-year collaboration with Tempus AI.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Whitehawk Therapeutics Stock Is Trading Higher Thursday: What's Going On?

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI Inc (NASDAQ:TEM) to support the development of its oncology pipeline.

MarketBeat

Tempus AI Hits $100—Are Shares Due for a Pullback?

After hitting $100, Tempus AI has retreated, but shares have still provided huge returns. Multiple factors suggest that the stock could see a larger correction.

Benzinga

Tempus AI Up Nearly 185% Since Nancy Pelosi's Reported Purchase In January 2025

Investors who followed the stock market disclosures from former House Speaker Nancy Pelosi would have seen significant returns, as an investment in the artificial intelligence health company Tempus AI Inc. (NASDAQ:TEM) has surged in value.

Benzinga

Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall

Tempus AI Inc (NASDAQ:TEM) has become one of 2025's most dramatic comeback stories. The stock soared past $100 this week, marking a new 52-week high and sending the market buzzing about the AI-powered cancer diagnostics company's growth prospects. Investors are taking note as the stock climbs amid recent FDA clearances…

Benzinga

Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock

Tempus AI Inc. (NASDAQ:TEM) shares are trending on Thursday.

MarketBeat

These 5 Beaten-Down Tech Stocks Could Catch Fire Next

Highly shorted stocks with positive growth outlooks and improving market support are set up for short squeezes: this is a look at five.

Benzinga

Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200%

Tracking the financial-market trades of members of Congress might be the ultimate investor edge—especially with one AI stock in Nancy Pelosi's portfolio now up over 200% since she bought in.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.